Stephen B. Hanauer, MD, FACG, is an Internationally recognized expert on the treatment of inflammatory bowel disease (IBD), former chair of the FDA Gastrointestinal Drugs Advisory Committee, and advisor on the development of multiple leading IBD drugs. He is a board-certified internist and gastroenterologist and is the Clifford Joseph Barborka Professor of Medicine and Medical Director of the Digestive Health Center at Northwestern University’s Feinberg School of Medicine.

Dr. Hanauer is a Fellow and past President of the American College of Gastroenterology (ACG) and the former Chair of the American Gastroenterological Association’s Inflammation, Immunology, and IBD Section. He is also a prior member of the Gastroenterology Specialty Board of the American Board of Internal Medicine and is a member and former Chairman of the International Organization for Inflammatory Bowel Disease.

Among his many honors, Dr. Hanauer received the AGA’s Fiterman Foundation Joseph B. Kirsner Award in Gastroenterology and the Janssen Award for Clinical Excellence. He has served as a member of the U.S. FDA Gastrointestinal Drugs Advisory Committee since 1987, he Chaired the Committee from 1998-2000, and he presently serves the Center for Drug Development and Research as a Special Consultant defining new guidelines for clinical evaluation of IBD patients. In 2020, he received the “Great Teachers” Award from the National Institute of Health (NIH) and was recognized as Master of the ACG. In 2021, he received the Mentoring Award from ACG and Digestive Health Foundation (DHF) Medical Leadership Award.

Dr. Hanauer has expertise in designing and leading clinical studies for IBD-related therapies and has acted as a clinical investigator and/or advisor to pharmaceutical companies in the development of many leading IBD therapies. He has authored over 475 peer-reviewed journal articles and numerous books and book chapters, abstracts, monographs, and editorials.